Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
08/07/2001 | US6270984 Modulating robo: ligand interactions |
08/07/2001 | US6270983 For use in immunoassays |
08/07/2001 | US6270982 Admixing crude amebocyte lysate with an ionic surfactant in an amount sufficient to produce a solution containing a precipitate; and separating precipitate from solution thereby to produce an amebocyte lysate preparation |
08/07/2001 | US6270981 Screening modulators of receptor binding activity; incubate enzymatic protein with phosphoprotein, monitoring binding, incubate enzymatic protein, phosphoprotein and modulator, monitor adjustment in enzymatic activty |
08/07/2001 | US6270980 Rapid methods for identifying modifiers of cellular apoptosis activity |
08/07/2001 | US6270979 Screening for modulators of preferential recptor activity; incubate cells and narcotic analgesic and monitor receptor activity in the presence and absence of modulator |
08/07/2001 | US6270978 Immunomethods for isolating and indentifying human influx peptide transporter |
08/07/2001 | US6270975 Nucleotide sequences for use in the diagnosis of viral infection |
08/07/2001 | US6270974 Exogenous nucleic acid detection |
08/07/2001 | US6270970 Mixed-bed solid phase and its use in the isolation of nucleic acids |
08/07/2001 | US6270964 Polypeptide used a diagnostic tool in genetic engineering |
08/07/2001 | US6270963 Method for testing for mutations in DNA from a patient sample |
08/07/2001 | US6270961 Analyzing nucleic acids by hybridization; incubate nucleotide sequences with oligonucleotides, detecting hybridization and analyze the results |
08/07/2001 | US6270960 Detecting microorganism in sample; incubate sample with preferential polypeptide and detect binding of preferential antibody |
08/07/2001 | US6270956 Polypeptide activator of gene expression; for use in treatment of preferential viral diseases and infections; for the detection of modulators of gene expression |
08/07/2001 | US6270955 Pharmaceutical compositions and methods for producing antibodies to hepatitis b virus and kits and methods for detecting antibodies to hepatitis b virus |
08/07/2001 | US6270954 Contacting first cell that expresses confonnationally defective target protein with protein stabilizing agent to improve conformational defect, thereby improving phenotypic defect of first cell where in congo red is not the stabilizer |
08/07/2001 | US6270953 Method for detecting and/or quantifying a gliotoxic factor |
08/07/2001 | US6270778 Relates to genes encoding melanoma antigens recognized by t-cells and their corresponding proteins. |
08/07/2001 | US6270776 Recombinant mycobacterial vaccine |
08/07/2001 | US6270772 Mhc class ii based molecules that comprise covalently linked beta 1 and alpha 1 domains, and mhc class i based molecules that comprise covalently linked alpha 1 and alpha 2 domains. |
08/07/2001 | US6270747 Inhibiting hypersecretion of mucus in lungs and airways by the administration of an egf-r antagonist. |
08/07/2001 | US6270746 Assay for the identification of IgE antibody suppressors |
08/07/2001 | US6270724 Including toxic contaminants, bacterial metabolites, and other microbial secretions. |
08/07/2001 | US6270695 Heterocyclic compounds with exocyclic double bond having phosphate group attached to distal carbon; detection sensitivity |
08/07/2001 | US6270637 Electrochemical biosensor test strip |
08/07/2001 | US6269679 System and method to characterize gas transport properties |
08/07/2001 | CA2217883C A device for detecting components in exhaled air |
08/07/2001 | CA2204887C Wrinkle reducing composition |
08/07/2001 | CA2079337C Method and device for solid phase microextraction and desorption |
08/07/2001 | CA2063607C Microelectrodes and their use in cathodic electrochemical current arrangement with telemetric application |
08/07/2001 | CA2025607C Hydrophilic derivatives, their application to diagnosis and to therapeutics, diagnostic or therapeutic kits and immunological reagents |
08/02/2001 | WO2001055967A2 Image metrics in the statistical analysis of dna microarray data |
08/02/2001 | WO2001055952A2 Method and system for collecting and transmitting chemical information |
08/02/2001 | WO2001055760A1 Method for producing a grid structure, an optical element, an evanescence field sensor plate, a microtitre plate and an optical communication engineering coupler as well as a device for monitoring a wavelength |
08/02/2001 | WO2001055736A1 Device for use in monitoring particulate flow |
08/02/2001 | WO2001055727A1 Immunological assay system and method |
08/02/2001 | WO2001055725A2 Diagnosis of tauopathies determining tau/phospho-tau ratio |
08/02/2001 | WO2001055724A1 Method for quantitating autoimmune disease antibody and quantification reagent and quantification kit therefor |
08/02/2001 | WO2001055723A1 Immunochromatographic assay devices with separators |
08/02/2001 | WO2001055722A1 Detection of biological target |
08/02/2001 | WO2001055721A2 Detection of biomolecules in gels following electrophoresis |
08/02/2001 | WO2001055720A2 A system for developing assays for personalized medicine |
08/02/2001 | WO2001055719A2 Diagnostic kit for detecting creatine levels |
08/02/2001 | WO2001055718A1 Device and method for detecting deposit formations on sensor surfaces, said formations being caused by lubricants |
08/02/2001 | WO2001055717A1 Method for monitoring an aqueous system |
08/02/2001 | WO2001055716A1 Method for evaluating concentration of metallic impurities in silicon wafer |
08/02/2001 | WO2001055715A2 Device and method for detecting the coagulation functions of global, especially primary hemostasis |
08/02/2001 | WO2001055714A1 Method and apparatus for concentrating samples for analysis |
08/02/2001 | WO2001055712A1 Measuring device using biosensor and biosensor used for it, and dedicated standard liquid |
08/02/2001 | WO2001055710A1 Carbon monoxide detector |
08/02/2001 | WO2001055709A1 Method and apparatus for measuring unattached radon progeny |
08/02/2001 | WO2001055708A2 Method of processing a sample containing at least one biological element |
08/02/2001 | WO2001055704A1 System for transferring fluid samples through a sensor array |
08/02/2001 | WO2001055703A1 Method of preparing a sensor array |
08/02/2001 | WO2001055702A1 Portable sensor array system |
08/02/2001 | WO2001055701A1 System and method for the analysis of bodily fluids |
08/02/2001 | WO2001055698A1 MEASUREMENT OF SOLUBILITY-pH PROFILES |
08/02/2001 | WO2001055693A1 Method for isolating a portion of a layer of a biological material |
08/02/2001 | WO2001055692A2 Neurosteroids as markers for alzheimer's disease |
08/02/2001 | WO2001055691A2 Waveguide plate and sensor platforms based thereon, arrangements of sample containers and detection methods |
08/02/2001 | WO2001055501A1 Method for determining a characteristic value for the binding force potential of suspended paper fibers and use of this method |
08/02/2001 | WO2001055485A1 Silicon wafer, method for determining condition under which silicon single crystal is produced, and method for producing silicon wafer |
08/02/2001 | WO2001055452A1 In vivo protein-protein interaction mapping |
08/02/2001 | WO2001055446A1 Novel stabilized formulations for chemiluminescent assays |
08/02/2001 | WO2001055444A1 Method for the evaluation of implantable materials |
08/02/2001 | WO2001055440A1 Nucleic acids, proteins, and antibodies |
08/02/2001 | WO2001055430A1 17 human secreted proteins |
08/02/2001 | WO2001055392A2 Nuclear hormone receptors |
08/02/2001 | WO2001055391A2 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
08/02/2001 | WO2001055389A1 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
08/02/2001 | WO2001055366A1 T cell receptor libraries |
08/02/2001 | WO2001055365A1 Support for fixing nucleotide and process for producing the same |
08/02/2001 | WO2001055358A2 Phosphodiesterases |
08/02/2001 | WO2001055349A1 Modulation of tolerance by altering nfat signalling |
08/02/2001 | WO2001055346A2 System for the internal qualitative and quantitative validation of marker indices |
08/02/2001 | WO2001055345A2 Method for producing a serum-containing culture medium for cells and the use thereof |
08/02/2001 | WO2001055337A2 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
08/02/2001 | WO2001055336A2 Methods and materials relating to cd84-like polypeptides and polynucleotides |
08/02/2001 | WO2001055333A2 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides |
08/02/2001 | WO2001055216A1 Methods and compositions for generating human monoclonal antibodies |
08/02/2001 | WO2001055210A2 Human cyr61 |
08/02/2001 | WO2001055178A2 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
08/02/2001 | WO2001055177A2 Methods to identify ctl epitopes of hiv |
08/02/2001 | WO2001055170A1 Mob-5/hmob-5 as a cancer diagnostic marker |
08/02/2001 | WO2001055047A2 Assay methods for hydratable cementitious compositions |
08/02/2001 | WO2001055035A2 Device for treating water |
08/02/2001 | WO2001055022A1 Method for detecting break point of thread and apparatus therefor |
08/02/2001 | WO2001054814A2 Compositions and methods for performing biological reactions |
08/02/2001 | WO2001054813A2 Devices and methods for biochip multiplexing |
08/02/2001 | WO2001054731A2 Ligand conjugates and methods for preparing same |
08/02/2001 | WO2001054723A1 Therapeutic method for reducing angiogenesis |
08/02/2001 | WO2001054713A1 Methods for determining risk of developing cervical cancer |
08/02/2001 | WO2001054712A1 Compositions and methods for the early diagnosis of ovarian cancer |
08/02/2001 | WO2001054707A2 Modification of surface proteins by aminopeptidase inhibitors |
08/02/2001 | WO2001054552A1 Disposable surface wipe article having a waste contamination sensor |
08/02/2001 | WO2001018550A3 Determination of adrenomedullin-binding proteins |
08/02/2001 | WO2001018537A3 Process for determining the acidity of a washing solution for fibres |
08/02/2001 | WO2001018059A3 Congener independent detection of microcystin and nodularin congeners |
08/02/2001 | WO2001016373A3 Assaying of mitochondrial intermembrane space protein translocation |